Gilead Sciences, Inc
BMV:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences, Inc
BMV:GILD
|
US |
|
F
|
Fujitec Co Ltd
F:FJC
|
JP |
|
Toast Inc
NYSE:TOST
|
US |
|
N
|
Nextera Energy Inc
XMUN:FP3
|
US |
|
Japan Excellent Inc
F:81L
|
JP |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
O
|
Occidental Petroleum Corp
DUS:OPC
|
US |
|
Pharvaris NV
F:9EN
|
NL |
|
M&G PLC
F:7MP
|
UK |
|
E
|
eBay Inc
XETRA:EBA
|
US |
|
A
|
Align Technology Inc
F:AFW
|
US |
|
Platt Nera International Ltd
HKEX:1949
|
TH |
|
Cicor Technologies Ltd
F:CRLN
|
CH |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Bank Central Asia Tbk PT
OTC:PBCRY
|
ID |
Bankruptcy Probability
Gilead Sciences, Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences, Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
130.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
87.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
31.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences, Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences, Inc has total debt of 23.8B USD. This includes both short-term (0 USD) and long-term (23.8B USD) debt.
You can find a full breakdown on its Balance Sheet.
